You are here
Kytopen Corp
UEI: NGLCLMGPFSV6
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Non-Activated Natural Killer Cell Engineering For Enhanced Cytotoxic Potential
Amount: $300,000.00ABSTRACT Natural killer (NK) cells are a subset of innate immune cells that are able to respond to threat without antibody priming. This quick response to stimuli makes them an ideal immunotherapy can ...
SBIRPhase I2021Department of Health and Human Services National Institutes of Health -
SBIR Phase II: An Automated Platform for Rapid Discovery in Cell Biology
Amount: $948,152.00The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to develop a fast, efficient, and scalable cell engineering technology that is easily auto ...
SBIRPhase II2019National Science Foundation -
SBIR Phase I: A scalable high-throughput cell engineering platform
Amount: $225,000.00The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development a scalable, automated, genetic transformation platform that is 10,000X faster than ...
SBIRPhase I2018National Science Foundation